[144/A] CompoSecure, Inc. SEC Filing
Form 144/A notice documents a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1,796,000.00 and an indicated trading venue of Nasdaq. The filing lists 102,317,852 shares outstanding and an approximate sale date of 08/12/2025. The securities to be sold were acquired as restricted stock units: 62,500 vested on 01/01/2023 and 37,500 vested on 01/01/2024, both shown as vesting from Composecure Inc. The form reports "Nothing to Report" for sales in the past three months and includes the standard signature representation about absence of undisclosed material adverse information. Several administrative fields (filer and issuer name/details and signature/date) are not populated in the visible content.
Avviso Modulo 144/A documenta una proposta di vendita di 100.000 azioni ordinarie tramite Edward Jones con un valore di mercato complessivo di $1.796.000,00 e un mercato di negoziazione indicato come Nasdaq. Il deposito indica 102.317.852 azioni in circolazione e una data approssimativa di vendita del 08/12/2025. I titoli da vendere sono stati acquisiti come unità di azioni vincolate (RSU): 62.500 sono maturate il 01/01/2023 e 37.500 il 01/01/2024, entrambe risultano maturate da Composecure Inc. Il modulo riporta "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione di firma relativa all'assenza di informazioni materiali sfavorevoli non divulgate. Alcuni campi amministrativi (nome/dettagli del dichiarante e dell'emittente e firma/data) non sono compilati nel contenuto visibile.
Aviso Formulario 144/A documenta una propuesta de venta de 100.000 acciones ordinarias a través de Edward Jones con un valor de mercado agregado de $1,796,000.00 y un mercado de negociación indicado como Nasdaq. La presentación lista 102,317,852 acciones en circulación y una fecha aproximada de venta del 08/12/2025. Los valores a vender se adquirieron como unidades de acciones restringidas: 62,500 adquiridas el 01/01/2023 y 37,500 el 01/01/2024, ambas procedentes de Composecure Inc. El formulario informa "Nothing to Report" respecto a ventas en los últimos tres meses e incluye la representación de firma estándar sobre la ausencia de información adversa material no divulgada. Varios campos administrativos (nombre/detalles del declarante y del emisor y firma/fecha) no están completados en el contenido visible.
Form 144/A 통지는 Edward Jones를 통해 총 시장가치가 $1,796,000.00100,000 보통주102,317,852주로 기재되어 있고, 예정 매도일은 대략 08/12/2025로 표시되어 있습니다. 매도될 증권은 제한부 주식 단위(RSU)로 취득되었으며: 62,500주는 01/01/2023에 권리확정(vested)되었고 37,500주는 01/01/2024에 권리확정되었으며, 두 건 모두 Composecure Inc에서의 권리확정으로 표시되어 있습니다. 양식에는 지난 3개월간 매도에 대해 "Nothing to Report"로 보고되어 있으며, 미공개 중대한 불리한 정보의 부재에 관한 표준 서명 진술을 포함하고 있습니다. 몇몇 행정 항목(신고자 및 발행인 이름/세부사항, 서명/날짜)은 표시된 내용에 기입되어 있지 않습니다.
Avis Formulaire 144/A documente une proposition de vente de 100 000 actions ordinaires via Edward Jones pour une valeur marchande totale de $1,796,000.00 et un lieu de négociation indiqué Nasdaq. Le dépôt indique 102,317,852 actions en circulation et une date approximative de vente le 08/12/2025. Les titres à vendre ont été acquis sous forme d'unités d'actions restreintes (RSU) : 62,500 ont été acquises le 01/01/2023 et 37,500 le 01/01/2024, toutes deux indiquées comme provenant de Composecure Inc. Le formulaire indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la déclaration standard signée relative à l'absence d'informations défavorables importantes non divulguées. Plusieurs champs administratifs (nom/détails du déclarant et de l'émetteur ainsi que signature/date) ne sont pas renseignés dans le contenu visible.
Formular 144/A Hinweis dokumentiert einen geplanten Verkauf von 100.000 Stammaktien über Edward Jones mit einem aggregierten Marktwert von $1.796.000,00 und dem angegebenen Handelsplatz Nasdaq. Die Einreichung weist 102.317.852 ausstehende Aktien aus und nennt ein ungefähres Verkaufsdatum 08/12/2025. Die zum Verkauf stehenden Wertpapiere wurden als Restricted Stock Units erworben: 62.500 sind am 01/01/2023 fällig geworden und 37.500 am 01/01/2024, beide als Vesting von Composecure Inc ausgewiesen. Das Formular vermerkt "Nothing to Report" für Verkäufe in den letzten drei Monaten und enthält die übliche unterschriebene Erklärung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen. Mehrere Verwaltungsfelder (Name/Angaben des Einreichenden und des Emittenten sowie Unterschrift/Datum) sind im sichtbaren Inhalt nicht ausgefüllt.
- 100,000 common shares clearly identified for proposed sale with aggregate market value $1,796,000.00
- Securities were acquired via RSU vesting on 01/01/2023 and 01/01/2024, shown as vesting events
- Filing reports "Nothing to Report" for securities sold in the past three months
- The visible filing content does not populate filer identity or complete issuer name/address fields
- No signature or explicit date of notice values are shown in the provided text, limiting verification
- Form text contains minor inconsistencies in naming (e.g., Composecure Inc appears as the RSU source while issuer fields are blank)
Insights
TL;DR: Routine Rule 144/A notice for vested RSUs; specified sale appears procedural and not materially disruptive.
The filing shows a proposed sale of 100,000 common shares through Edward Jones with an aggregate market value of $1.796M and identifies the shares as resulting from RSU vesting on 01/01/2023 and 01/01/2024. The form records no sales in the prior three months. As presented, this is a standard disclosure of intent to sell restricted stock under Rule 144 rather than a corporate financing or strategic transaction; the document provides limited operational or financial detail about the issuer itself.
TL;DR: Administrative filing includes required representations but some issuer/filer fields are not populated in the visible content.
The notice contains the required statement that the person signing does not possess undisclosed material adverse information and references Rule 10b5-1 trading-plan language if applicable. However, key administrative fields (filer identity, issuer name/address and signature/date entries) are not shown in the provided text, limiting transparency about the selling party and the formal execution of the notice. The lack of populated filer/issuer fields reduces the filing's standalone clarity for investors.
Avviso Modulo 144/A documenta una proposta di vendita di 100.000 azioni ordinarie tramite Edward Jones con un valore di mercato complessivo di $1.796.000,00 e un mercato di negoziazione indicato come Nasdaq. Il deposito indica 102.317.852 azioni in circolazione e una data approssimativa di vendita del 08/12/2025. I titoli da vendere sono stati acquisiti come unità di azioni vincolate (RSU): 62.500 sono maturate il 01/01/2023 e 37.500 il 01/01/2024, entrambe risultano maturate da Composecure Inc. Il modulo riporta "Nothing to Report" per vendite negli ultimi tre mesi e include la consueta dichiarazione di firma relativa all'assenza di informazioni materiali sfavorevoli non divulgate. Alcuni campi amministrativi (nome/dettagli del dichiarante e dell'emittente e firma/data) non sono compilati nel contenuto visibile.
Aviso Formulario 144/A documenta una propuesta de venta de 100.000 acciones ordinarias a través de Edward Jones con un valor de mercado agregado de $1,796,000.00 y un mercado de negociación indicado como Nasdaq. La presentación lista 102,317,852 acciones en circulación y una fecha aproximada de venta del 08/12/2025. Los valores a vender se adquirieron como unidades de acciones restringidas: 62,500 adquiridas el 01/01/2023 y 37,500 el 01/01/2024, ambas procedentes de Composecure Inc. El formulario informa "Nothing to Report" respecto a ventas en los últimos tres meses e incluye la representación de firma estándar sobre la ausencia de información adversa material no divulgada. Varios campos administrativos (nombre/detalles del declarante y del emisor y firma/fecha) no están completados en el contenido visible.
Form 144/A 통지는 Edward Jones를 통해 총 시장가치가 $1,796,000.00100,000 보통주102,317,852주로 기재되어 있고, 예정 매도일은 대략 08/12/2025로 표시되어 있습니다. 매도될 증권은 제한부 주식 단위(RSU)로 취득되었으며: 62,500주는 01/01/2023에 권리확정(vested)되었고 37,500주는 01/01/2024에 권리확정되었으며, 두 건 모두 Composecure Inc에서의 권리확정으로 표시되어 있습니다. 양식에는 지난 3개월간 매도에 대해 "Nothing to Report"로 보고되어 있으며, 미공개 중대한 불리한 정보의 부재에 관한 표준 서명 진술을 포함하고 있습니다. 몇몇 행정 항목(신고자 및 발행인 이름/세부사항, 서명/날짜)은 표시된 내용에 기입되어 있지 않습니다.
Avis Formulaire 144/A documente une proposition de vente de 100 000 actions ordinaires via Edward Jones pour une valeur marchande totale de $1,796,000.00 et un lieu de négociation indiqué Nasdaq. Le dépôt indique 102,317,852 actions en circulation et une date approximative de vente le 08/12/2025. Les titres à vendre ont été acquis sous forme d'unités d'actions restreintes (RSU) : 62,500 ont été acquises le 01/01/2023 et 37,500 le 01/01/2024, toutes deux indiquées comme provenant de Composecure Inc. Le formulaire indique "Nothing to Report" pour les ventes des trois derniers mois et inclut la déclaration standard signée relative à l'absence d'informations défavorables importantes non divulguées. Plusieurs champs administratifs (nom/détails du déclarant et de l'émetteur ainsi que signature/date) ne sont pas renseignés dans le contenu visible.
Formular 144/A Hinweis dokumentiert einen geplanten Verkauf von 100.000 Stammaktien über Edward Jones mit einem aggregierten Marktwert von $1.796.000,00 und dem angegebenen Handelsplatz Nasdaq. Die Einreichung weist 102.317.852 ausstehende Aktien aus und nennt ein ungefähres Verkaufsdatum 08/12/2025. Die zum Verkauf stehenden Wertpapiere wurden als Restricted Stock Units erworben: 62.500 sind am 01/01/2023 fällig geworden und 37.500 am 01/01/2024, beide als Vesting von Composecure Inc ausgewiesen. Das Formular vermerkt "Nothing to Report" für Verkäufe in den letzten drei Monaten und enthält die übliche unterschriebene Erklärung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen. Mehrere Verwaltungsfelder (Name/Angaben des Einreichenden und des Emittenten sowie Unterschrift/Datum) sind im sichtbaren Inhalt nicht ausgefüllt.
FAQ
What sale does the CMPO 144/A notice disclose?
When is the approximate sale date listed in the filing for CMPO?
How were the shares to be sold acquired according to the form?
Which broker is named for the proposed sale in the CMPO filing?
Does the filing show recent sales by the reporting person?
Who is identified as the issuer in the filing?
